Neuroscience – Lifeboat News: The Blog

Nov 3
2015

How Facebook Will Use Artificial Intelligence to Understand Your Entire Social Life

Short Bytes: Artificial Intelligence holds a special place in the future of the humanity. Many tech giants, including Facebook, have long been working on improving the AI to make lives better. Facebook has decided to reveal its milestones in Artificial Intelligence Research in the form of a progress report.

It doesn’t matter if you are scared of AI like Elon Musk or Stephen Hawking or if you have an opinion same as that of Google’s chief of Artificial Intelligence that computers are remarkably dumb. Companies are still going through the byzantine process of training the machines and creating human brain algorithms. Meanwhile, Facebook has just announced its progress report.

Facebook’s AI research team (FAIR) will present at NIPS, an Artificial Intelligence conference, its report card and reveal the team’s achievements regarding its state-of-the-art systems. Facebook has been trying to improve the image recognition and has created a system that speeds up the process by 30% using 10 times less training data from previous benchmarks.

Nov 2
2015

Cryonics Is No Fantasy, Should We Be Taking It Seriously?

Most science starts off at the fringe and slowly makes it way to the mainstream. Cryopreservation is commonly achieved in a laboratory setting, but for many years serious applications remained confined to science fiction. Is it time to change how we see cryonics?

The science of freezing things

Scientific research requires great storage, and huge amounts of material including cells are frozen every day to be used at the later date. If you follow the correct protocols, many forms of life can be re-awakened after their cryogenic sleep. DMSO, propylene glycol and glycerol help abolish problems like ice crystals which can rupture cells, and storage temperatures can drop to below −120 oC. At these levels biological reactions are essentially halted.

Nov 2
2015

Phenylpiracetam: The Effects, Usages and Dosages

Phenylpiracetam, a water-soluble racetam, has neuro modulating and nootropic effects. Before any usage, it is beneficial to know the general dosages.

Oct 30
2015

Mind Control Device Alters Emotions on Demand

Think of all the possibilities!

Mind control has been a topic of many great suspense and science fiction movies until recent. Now, an emotion altering device that will work in conjunction with a smart phone app is now being developed by Thync, and is slated for release to the public in 2015.

Thync announced on Oct. 8 that it’s raised $13 million from financial contributors to develop technology combining neuroscience and consumer electronics.

“This is an avenue for people to call up their best stuff on demand,” says Isy Goldwasser, Thync’s chief executive officer and co-founder. “It’s a way for us to overcome our basic limitation as people. It lets us call up our focus, our calm, and creativity when we need it.”

Oct 30
2015

The Autopilot is learning fast: Model S owners are already reporting that Tesla’s Autopilot is self-improving

During the press conference for the release of the Autopilot, Tesla CEO Elon Musk referred to each Model S owners as “expert trainers” – meaning that each driver will train the autonomous features of the system to feed the collective network intelligence of the fleet by simply driving the electric vehicle on Autopilot.

He said that the system should improve everyday, but that improvements might only become noticeable every week or so by adding up. Just a few weeks after the release, Model S owners are already taking to the Tesla Motors Club forum to describe how the Autopilot is improving…

Oct 26
2015

BioViva Presents: Alzheimer’s Disease and Gene Therapy

Adam Alonzi has made another excellent film about the power of gene therapy.

Narrated and produced by Adam Alonzi. Music arranged by Leslee Frost. Sponsored by BioViva Sciences Inc.

Alzheimer’s Disease.
Alzheimer’s disease is a progressive, neurodegenerative disorder. It is the leading cause of dementia. Typically the condition affects short-term memory, but as it advances it can result in disorientation, mood disorders, language difficulties and behavioral issues. Over time, body functions are lost, leading to death.

Current treatment options are extremely limited and the outlook is poor for sufferers with the average life expectancy being 3–9 years from diagnosis. According to RAND Corp, the average annual cost of care for someone with Alzheimer’s disease is $41,689 to $56,290.

BioViva’s Therapy — Telomerase AAV gene therapy.

We are exploring therapies with the gene that creates telomerase to rejuvenate the microglia cells that support the Neurons with the aim of combating Alzheimer’s disease and restoring healthy function to the brain once more. There is mounting evidence to indicate this gene plays an active role in protection from Tau Pathology and various experiments have encouraged us to pursue this therapy with the goal of eliminating the suffering this disease brings.

Continue reading “BioViva Presents: Alzheimer’s Disease and Gene Therapy” | >

Oct 25
2015

Scientists Connect Brain to a Basic Tablet—Paralyzed Patient Googles With Ease

That was the year she learned to control a Nexus tablet with her brain waves, and literally took her life quality from 1980s DOS to modern era Android OS.

A brunette lady in her early 50s, patient T6 suffers from amyotrophic lateral sclerosis (also known as Lou Gehrig’s disease), which causes progressive motor neuron damage. Mostly paralyzed from the neck down, T6 retains her sharp wit, love for red lipstick and miraculous green thumb. What she didn’t have, until recently, was the ability to communicate with the outside world.

Oct 25
2015

Fighting Aging With Gene Therapy: An Exclusive Interview With Liz Parrish, The Pioneer Who Wants To Keep You Young

Nice interview by The Longevity Reporter about BioViva Sciences Inc.

Liz Parrish isn’t your average CEO. A passionate advocate for change, her.
company BioViva is leading the fight for healthy longevity with pioneering.
gene therapies targeting Alzheimer’s, sarcopenia and even aging itself.
Parrish dreams big, but she’s a woman of action. She’s even demonstrated.
her commitment by testing cutting-edge therapies on herself. Could her.
efforts change how we think about aging? Is gene therapy the future or are.
we moving too fast? We caught up with the woman herself to find out more.

Oct 24
2015

Consciousness has less control than believed, according to new theory

Consciousness — the internal dialogue that seems to govern one’s thoughts and actions — is far less powerful than people believe, serving as a passive conduit rather than an active force that exerts control, according to a new theory proposed by an SF State researcher.

Associate Professor of Psychology Ezequiel Morsella

Associate Professor of Psychology Ezequiel Morsella.

Oct 22
2015

Haptics Technology: Soon, We Might Be Able To ‘Feel’ Cyberspace

Haptics is a growing field that aims to allow our bodies to control and ultimately ‘feel’ our virtual identity. Instead of using the theorized mechanism of a neural computer link, haptic tech attaches sensors and stimuli to our body. A report by research firm Markets and Markets thinks haptic technology, which could soon include something like a glove that let’s you move a hand in cyberspace, will be worth 30 billion by 2020.

Haptic technology, also known as kinesthetic communication, sounds like something out of science fiction. But products, like the vibrating cell phone, have been out for decades. And there’s more advanced systems on the way. That’s partly because of another hyped field: virtual reality. With pioneering virtual reality headsets like the Oculus Rift poised for release next year, the question becomes: How to make this experience even more immersive.

The tech is based on our sense of touch, a sensation that philosopher John Locke believed to be the most undeniable of all human senses. We believe something is real by touching it, a philosophy that haptic technology follows.